To unbiasedly profile endogenous immune cells, we performed scRNA-seq analysis of the F331 tumor model on day 21 post Ctrl KO or Reg-1 KO B7-H3-CAR T-cell infusion (Fig. 6A). This evidence concerns the gene CD276 and neoplasm.